Clinical pharmacist staffing in United States hospitals

Pharmacotherapy

Volumn 22, Issue 11, 2002, Pages 1489-1499

  Bond, C A ^a   Raehl, Cynthia L ^a   Franke, Todd ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATIVE PERSONNEL; ARTICLE; CLINICAL PHARMACOLOGY; DEMOGRAPHY; HOSPITAL PHARMACY; HUMAN; MULTIPLE REGRESSION; PHARMACIST; STAFF; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; DATABASES, FACTUAL; HOSPITALS; HUMANS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; REGRESSION ANALYSIS; UNITED STATES;

EID: 0036843402     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.16.1489.33689     Document Type: Article

References (62)

1. Black BL. Resource Book on Progressive Pharmaceutical Services. Bethesda, MD: American Society of Hospital Pharmacists, 1986.
2. Hatoum HT, Catizone C, Hutchinson RA, et al. An eleven-year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
3. Comptroller General of the United States. Study of Health Facilities Construction Costs. Washington, DC: U.S. Government Printing Office, 1972:68-72, 363-79.
4. Barker KN, Pearson RE. Medication distribution systems. In: Brown TR, Smith, MC, eds. Handbook of Institutional Pharmacy Practice. Baltimore: Williams & Wilkins, 1986:325-51.
5. Elenbaas RM, Payne VW, Bauman JL. Influence of clinical pharmacists consultations on the use of blood level test. Am J Hosp Pharm 1980;37:61-4.
6. Bollish SJ, Kelly WN, Miller DE, et al. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital. Am J Hosp Pharm 1981;38:73-6.
7. Abramowitz PA, Nold EC, Hatfield SM. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm 1982;39:1176-80.
8. Mutchie KD, Smith KA, MacKay MW, et al. Pharmacist's monitoring of parenteral nutrition: Clinical and cost effectiveness. Am J Hosp Pharm 1979;36:785-7.
9. Covinsky JO, Hamburger SC, Kelly KL, et al. Impact of docent clinical pharmacists on treatment of streptococcal pneumonia. Drug Intell Clin Pharm 1982;16:587-91.
10. Bond CA, Salinger RJ. Fluphenazine outpatient clinics: A pharmacist's role. J Clin Psychiatry 1979;40:501-3.
11. Herfindal ET, Bernstein LR, Kishi DT. Effect of clinical pharmacy services on prescribing on an orthopedic unit. Am J Hosp Pharm 1983;40:1945-51.
12. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63.
13. Knapp DE, Knapp DA, Speedie MK, et al. Relationship of inappropriate drug prescribing to increased length of hospital stay. Am J Hosp Pharm 1979;36:1334-7.
14. Knapp DE, Speedie MK, Yaeger DM, et al. Drug prescribing and its relationship to length of hospital stay. Inquiry 1980;17:254-9.
15. McKenney JM, Wasserman AH. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions. Am J Hosp Pharm 1979;36:1691-7.
16. Clapham CE, Hepler CE, Reinders TP, et al. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988;45:2329-40.
17. Bjornson DC, Hiner WO, Potyk RP, et al. Effect of pharmacist on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
18. Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy 1996;16(4):708-14.
19. Monson RA, Bond CA, Schuna A. Role of the clinical pharmacist in improving outpatient drug therapy. Arch Intern Med 1981;141:1441-4.
20. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control - A four year ambulatory care model. Arch Intern Med 1984;144:1159-62.
21. Tang I, Vrahnos D, Hatoum H, et al. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993;154:59-64.
22. Brown WJ. Pharmacist participation on a multidisciplinary rehabilitation team. Am J Hosp Pharm 1994;51:91-2.
23. Garber AM, Fuchs VR, Silverman JF. Case mix, costs, and outcomes between faculty and community services in a university hospital. N Engl J Med 1984;310:1231-7.
24. Pauly MV, Wilson P. Hospital output forecasts and the cost of empty hospital beds. Health Serv Res 1986;21:413-28.
25. Rich EC, Gifford G, Luxenberg M, et al. The relationship of hospital staff experiences to the cost and quality of inpatient care. JAMA 1990;263:953-7.
26. Watts CA, Klastorin TD. The impact of case-mix on hospital costs: A comparative analysis. Inquiry 1990;17:357-67.
27. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluation of clinical pharmacy services-1988-1995. Pharmacotherapy 1996;16(6):1188-208.
28. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure team. Arch Intern Med 1999;159:1939-45.
29. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
30. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20.
31. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999;19(5):767-81.
32. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: Summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 2001;21(2):129-41.
33. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals. Pharmacotherapy 1999;19(12):1354-62.
34. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 2000;20(6);609-21.
35. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002;22(2):134-47.
36. Bond CA, Raehl CL, Pitterle ME. 1992 National clinical pharmacy services study. Pharmacotherapy 1994;14(3):282-304.
37. Kuhn EM, Hartz AJ, Gottlieb MS, Rimm AA. The relationship of hospital characteristics and results of peer review in six large hospitals. Med Care 1991;29:1028-38.
38. Green J, Passman LJ, Wintfield N. Analyzing hospital mortality-the consequences of diversity in patient mix. JAMA 1991;265:1849-53.
39. Hartz AJ, Gottlieb M, Kuhn EM, Rimm A. A National Validation Study of Medicare Mortality Studies (Project #1247-M). Technical report to the Health Standards Review Bureau, Washington, DC, 1989.
40. Hartz AJ, Krakauer H, Kuhn EM, et al. Hospital characteristics and mortality rates. N Engl J Med 1989;321:1720-5.
41. Kelly JV, Hellinger FJ. Physician and hospital factors associated with mortality in surgical patients. Med Care 1986;24:785-800.
42. Shortell SM, Hughes EFX. The effect of regulation, competition, and ownership on mortality rates among hospital inpatients. N Engl J Med 1988;318:1100-7.
43. Daley J, Jencks S, Draper D, et al. Predicting hospital-associated mortality for Medicare patients. JAMA 1988;260:3617-24.
44. Bond CA, Raehl CL, Pitterle ME. Cost of pharmaceutical services in U.S. hospitals in 1992. Am J Hosp Pharm 1995;52:503-13.
45. Raehl CL, Bond CA. 1998 National clinical pharmacy services study. Pharmacotherapy 2000;20(4):436-60.
46. Raehl CL, Bond CA, Pitterle ME. 1995 National clinical pharmacy services survey. Pharmacotherapy 1998;18(2):282-304.
47. Raehl CL, Bond CA, Pitterle ME. Hospital pharmacy services in the Great Lakes region. Am J Hosp Pharm 1990;47:1283-1303.
48. Raehl CL, Bond CA, Pitterle ME. Pharmaceutical services in U.S. hospitals in 1989. Am J Hosp Pharm 1992;49:323-46.
49. Pitterle ME, Bond CA, Raehl CL, Franke T. Hospital and pharmacy characteristics associated with mortality rates in United States hospitals. Pharmacotherapy 1994;14(5):620-30.
50. Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999;19(2):130-8.
51. American Hospital Association. Abridged Guide to the Healthcare Field [on Diskettes]. Chicago: American Hospital Association, 1992.
52. Wampole BE, Freund RD. Use of multiple regression in counseling psychology research: A flexible data analytic strategy J Counsel Psychol 1987;34:372-82.
53. Pedhazur EJ. Multiple Regression in Behavioral Research: Explanation and Prediction, 2nd Ed. New York: Harcourt Brace Jovanovich, 1982.
54. Bond CA, Pitterle ME, Raehl CL. Cost of inpatient pharmaceutical services in U.S. hospitals in 1989. Am J Hosp Pharm 1992;49:347-67.
55. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy 2001;21(9):1023-36.
56. Bond CA, Raehl CL, Franke T. Staffing and the cost of clinical pharmacy services in United States hospitals. Pharmacotherapy 1999;19(6):767-81.
57. Grogran JE, Hanna JA, Haight RA. A study of accuracy of pharmacy technicians working in a unit dose system. Hosp Pharm 1978;13:194-201.
58. Becker MD, Johnson MH, Longe RL. Errors remaining in unit dose carts after checking by pharmacists versus pharmacy technicians. Am J Hosp Pharm 1978;35:432-6.
59. Woller TW, Stuart J, Vrabel R, Senst B. Checking of unit dose cassettes by pharmacy technicians at three Minnesota hospitals. Am J Hosp Pharm 1991;48:1952-8.
60. Klammer GA, Ensom R. Pharmacy technician refill checking: Safe and practical. Can J Hosp Pharm 1994;47:117-23.
61. Ness JE, Sullivan SD, Stergachis A. Accuracy of technicians and pharmacists in identifying dispensing errors. Am J Hosp Pharm 1994;51:354-9.
62. Ambrose PJ, Saya FG, Lovett LT, Tan S, Adams DW, Shane R. Evaluating the accuracy of technicians and pharmacists in checking unit dose medication cassettes. Am J Health-Syst Pharm 2002;59:1183-8.